Compactin from hajós (−)-enedione

This publication has 15 references indexed in Scilit:

• Synthesis, SARs and therapeutic potential of HMG-CoA reductase inhibitors
  Trends in Pharmacological Sciences, 1987
• Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia
  The American Journal of Cardiology, 1987
• The Effect of CS-514, an Inhibitor of HMG-CoA Reductase, on Serum Lipids in Healthy Volunteers
  Atherosclerosis, 1986
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
• Structure elucidation of the bioactive metabolites of ML-236B (mevastatin) isolated from dog urine.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase
  Journal of Medicinal Chemistry, 1985
• Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B)
  The Journal of Antibiotics, 1983
• Microbial hydroxylation of ML-236B (compactin) Studies on microorganisms capable of 3.BETA.-hydroxylation of ML-236B.
  The Journal of Antibiotics, 1983
• Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
  Proceedings of the National Academy of Sciences, 1980
• ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
  The Journal of Antibiotics, 1976